Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1987-9-9
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0014-1755
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
24 Suppl 1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
61-7
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:3301333-Dapsone,
pubmed-meshheading:3301333-Drug Resistance, Microbial,
pubmed-meshheading:3301333-Drug Therapy, Combination,
pubmed-meshheading:3301333-Humans,
pubmed-meshheading:3301333-Leprostatic Agents,
pubmed-meshheading:3301333-Leprosy,
pubmed-meshheading:3301333-Mycobacterium leprae,
pubmed-meshheading:3301333-Patient Compliance
|
pubmed:year |
1986
|
pubmed:articleTitle |
Concepts behind the development of multiple drug therapy regimens in leprosy.
|
pubmed:publicationType |
Journal Article
|